BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND WT1, WAGR, 7490, ENSG00000184937, WT33, GUD, WIT-2 AND Treatment
55 results:

  • 1. Dendritic cell vaccination in combination with erlotinib in a patient with inoperable lung adenocarcinoma: a case report.
    Kosumi T; Kobayashi M; Shimodaira S; Sugiyama H; Koido S
    J Med Case Rep; 2024 Feb; 18(1):88. PubMed ID: 38336778
    [TBL] [Abstract] [Full Text] [Related]  

  • 2.
    Choi YJ; Min YK; Lee ST; Choi JR; Shin S
    Ann Lab Med; 2024 Jul; 44(4):335-342. PubMed ID: 38145892
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Leukemia Genotype Analysis of Children with Acute Lymphoblastic Leukemia in Yunnan Area].
    Shi SL; Kui LY; Xia SM; Zhou BL; Li RJ; Jiang HC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):980-984. PubMed ID: 37551465
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Locally advanced choroidal melanoma with favorable molecular prognosis - case report.
    Bălăşoiu AT; Ştefănescu-Dima AŞ; Bălăşoiu M; Ciurea RN; Muraru A; Dan AO; Simionescu CE
    Rom J Morphol Embryol; 2022; 63(4):645-652. PubMed ID: 36808200
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Integrated clinical genotype-phenotype characteristics of early T-cell precursor acute lymphoblastic leukemia.
    Ye MT; Wang Y; Zuo Z; Calin S; He H; Tang Z; Jabbour EJ; Borthakur G; Zhang Y; Yang Y; You MJ
    Cancer; 2023 Jan; 129(1):49-59. PubMed ID: 36281717
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Tumor-associated antigen-specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma.
    Dave H; Terpilowski M; Mai M; Toner K; Grant M; Stanojevic M; Lazarski C; Shibli A; Bien SA; Maglo P; Hoq F; Schore R; Glenn M; Hu B; Hanley PJ; Ambinder R; Bollard CM
    Blood Adv; 2022 Jan; 6(2):473-485. PubMed ID: 34495306
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Genomic Landscape of a Restricted ALL Cohort from Patients Residing on the U.S./Mexico Border.
    Grant AH; Ayala-Marin YM; Mohl JE; Robles-Escajeda E; Rodriguez G; Dutil J; Kirken RA
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299796
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
    Yao S; Jianlin C; Zhuoqing Q; Yuhang L; Jiangwei H; Guoliang H; Hongmei N; Bin Z; Liangding H
    Front Immunol; 2021; 12():639217. PubMed ID: 33868266
    [No Abstract]    [Full Text] [Related]  

  • 9. Deleterious point mutations in T-cell acute lymphoblastic leukemia: Mechanistic insights into leukemogenesis.
    Roy U; Raghavan SC
    Int J Cancer; 2021 Sep; 149(6):1210-1220. PubMed ID: 33634864
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Expressing of linc-223 and miR-125a in Patients with Acute Leukemia and Its Clinical Significance].
    Liu AF; Chen YJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1819-1825. PubMed ID: 33283704
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Clinical Research of Dendritic Cell-Mediated Tumor-Associated Antigen-Specific Cytotoxic T Lymphocytes in the treatment of Multiple Myeloma and Non-Hodgkin lymphoma].
    Li XH; Xue L; Xu H; Zhang XH; Liu X; Zhu WB; Wang XB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1750-1756. PubMed ID: 33067985
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. wt1 Expression in Peripheral Blood at Diagnosis and During the Course of Early Consolidation treatment Correlates With Survival in Patients With Intermediate and Poor-Risk Acute Myeloid Leukemia.
    Šálek C; Vydra J; Cerovská E; Šestáková Š; Ransdorfová Š; Válková V; Cetkovský P; Remešová H
    Clin Lymphoma Myeloma Leuk; 2020 Dec; 20(12):e998-e1009. PubMed ID: 32888885
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data.
    Fernández-Navarro P; López-Nieva P; Piñeiro-Yañez E; Carreño-Tarragona G; Martinez-López J; Sánchez Pérez R; Aroca Á; Al-Shahrour F; Cobos-Fernández MÁ; Fernández-Piqueras J
    BMC Cancer; 2019 Oct; 19(1):1005. PubMed ID: 31655559
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. wt1 regulates cyclin A1 expression in K562 cells.
    Pandey S; Moazam M; Ghimirey N; Kuerbitz SJ; Fraizer GC
    Oncol Rep; 2019 Nov; 42(5):2016-2028. PubMed ID: 31436300
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinical and biological features of PTPN2-deleted adult and pediatric T-cell acute lymphoblastic leukemia.
    Alcantara M; Simonin M; Lhermitte L; Touzart A; Dourthe ME; Latiri M; Grardel N; Cayuela JM; Chalandon Y; Graux C; Dombret H; Ifrah N; Petit A; Macintyre E; Baruchel A; Boissel N; Asnafi V
    Blood Adv; 2019 Jul; 3(13):1981-1988. PubMed ID: 31270080
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. ssExpression level of GAS6-mRNA influences the prognosis of acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation.
    Yang X; Shi J; Zhang X; Zhang G; Zhang J; Yang S; Wang J; Ke X; Fu L
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31028135
    [TBL] [Abstract] [Full Text] [Related]  

  • 17.
    Bordin F; Piovan E; Masiero E; Ambesi-Impiombato A; Minuzzo S; Bertorelle R; Sacchetto V; Pilotto G; Basso G; Zanovello P; Amadori A; Tosello V
    Haematologica; 2018 Feb; 103(2):266-277. PubMed ID: 29170254
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Validation of a Molecular Risk Score for Prognosis of Patients With Acute Promyelocytic Leukemia Treated With All-trans Retinoic Acid and Chemotherapy-containing Regimens.
    Hecht A; Doll S; Altmann H; Nowak D; Lengfelder E; Röllig C; Ehninger G; Spiekermann K; Hiddemann W; Weiß C; Hofmann WK; Nolte F; Platzbecker U
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):889-896.e5. PubMed ID: 28923666
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The diverse expression of the wt1 gene in patients with acquired bone marrow failure syndromes.
    You Y; Huo J; Lu S; Shao Y; Ge M; Shi J; Li X; Huang J; Huang Z; Zhang J; Wang M; Nie N; Zheng Y
    Leuk Lymphoma; 2018 Apr; 59(4):950-957. PubMed ID: 28728504
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Use of Wilms Tumor 1 Gene Expression as a Reliable Marker for Prognosis and Minimal Residual Disease Monitoring in Acute Myeloid Leukemia With Normal Karyotype Patients.
    Marjanovic I; Karan-Djurasevic T; Ugrin M; Virijevic M; Vidovic A; Tomin D; Suvajdzic Vukovic N; Pavlovic S; Tosic N
    Clin Lymphoma Myeloma Leuk; 2017 May; 17(5):312-319. PubMed ID: 28163010
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.